No abstract

No abstract

The aim of this study was to explore the protective effects of squalene supplementation on growth performance, oxidative status, and liver function of diquat-challenged broilers. One hundred forty-four 1-day-old male Ross 308 broiler chicks were allocated to 3 groups, and each group consisted of 6 replicates of 8 birds each. The three groups were as follows: 1) nonchallenged broilers fed with a basal diet (control group), 2) diquat-challenged broilers fed a basal diet, and 3) diquat-challenged broilers fed with a basal diet supplemented with 1.0 g/kg of squalene. Broilers were intraperitoneally injected with 20 mg/mL of diquat solution at a dosage of 1 mL/kg of BW or an equivalent amount of saline at 20 d. Compared with the control group, weight gain and BW change rate during 24 h after injection were decreased by diquat challenge ( P < 0.05), and the diquat-induced compromised growth performance was improved by squalene supplementation ( P < 0.05). Diquat administration reduced plasma superoxide dismutase activity and increased malondialdehyde accumulation and glutathione peroxidase activity in both plasma and the liver ( P < 0.05). In contrast, plasma glutathione peroxidase activity in diquat-challenged broilers was reduced by squalene supplementation ( P < 0.05). The hepatic glutathione level was reduced by diquat administration ( P < 0.05), whereas its level in plasma and the liver of diquat-challenged broilers was increased by squalene supplementation ( P < 0.05). The relative liver weight of broilers was increased by diquat challenge ( P < 0.05), with its value being intermediate in the squalene-supplemented group ( P > 0.05). The plasma aminotransferase activities and total bilirubin concentration were increased by diquat challenge ( P < 0.05), which were reduced by squalene supplementation ( P < 0.05). The mRNA abundance of hepatic nuclear factor erythroid 2–related factor 2 ( P < 0.05) was upregulated by diquat treatment, regardless of squalene supplementation. The mRNA abundance of hepatic glutathione peroxidase 1 and B-cell lymphoma/leukemia 2–associated X protein was upregulated by diquat challenge ( P < 0.05), which was reversed by squalene administration ( P < 0.05). Squalene increased NAD(P)H quinone dehydrogenase 1 mRNA abundance and decreased caspase 3 mRNA abundance in the liver of diquat-challenged broilers ( P < 0.05). The results suggested that squalene can increase weight gain, improve oxidative status, and alleviate liver injury in diquat-challenged broilers.

This study was conducted to investigate the effects of chromium propionate on egg production, egg quality, plasma biochemical parameters and egg chromium deposition in late-phase laying hens. Four hundred thirty-two 60-weeks old laying hens were divided into four groups of 108 birds per group according to egg production. The dietary treatments consisted of the basal diet adding with 0, 200, 400, and 600 μg/kg chromium as chromium propionate. All laying hens were given feed and water ad libitum for 8 weeks. The addition of 400 μg/kg Cr as chromium propionate increased egg production (P < 0.01) during the later 4 weeks, but decreased albumen height, yolk color score, and Haugh unit of eggs. Six hundred micrograms per kilogram Cr as chromium propionate supplementation improved shell thickness (P < 0.05). 200 μg/kg Cr as chromium propionate supplementation decreased the uric acid concentration by 31 % (P < 0.05). However, supplemental Cr did not affect the egg chromium deposition of hens (P > 0.05). These data indicated that feeding of late-phase laying hens with chromium propionate could improve egg production, increase eggshell thickness, but do not result in abnormal levels of chromium deposition in eggs.

SummaryA biologically active peptide derived from soybeans by enzymatic hydrolysis was evaluated for its potential benefits on chicken growth performance, apparent ileal nutrient digestibility and intestinal histology in young broilers. Seven broiler starter diets, based on maize and soybean meal, were formulated to contain 0.0, 1.0, 2.0, 3.0, 4.0, 5.0 and 6.0 g/kg of a commercial soybean bioactive peptide (SBP) product (Fortide, Chengdu Mytech Biotech Co. Ltd., Chengdu, Sichuan, China). All diets were equivalent in respect of energy density, and digestible protein, amino acids, and other nutrients. A total of 336, one-day-old male broilers (Ross 308) were allocated to 42 cages (eight birds/cage), which were randomly assigned to the six dietary treatments. There was no significant effect of SBP on weight gain and feed intake of the birds. A significant (P < 0.01) effect of SBP was observed for FCR. Inclusion of 1.0, 2.0, 3.0 and 4.0 g SBP/kg of feed resulted in similar FCR values to the diet with no SBP, addition of SBP to the diets at 5.0 and 6.0 g/kg of feed resulted in lower (P < 0.05) FCR compared to the diet with no SBP. Inclusion of SBP had no effect (P > 0.05) on apparent ileal digestibility of nutrients and energy utilisation. Though not statistically significant, SBP inclusion, regardless of level, resulted in 5.7% and 6.3% increases in digestibility of dry matter and nitrogen, respectively. Birds receiving no SBP had the shortest villi and those fed SBP at 3.0 and 6.0 g/kg of feed tended (P = 0.075) to have the greatest villus height. The current findings suggested that including SBP in broiler diets may benefit production through improving feed efficiency, and, to some extent, nutrient digestion and intestinal histology parameters.